. Presence of CAFs in ascitic MCAs. (A) Representative images of immunohistochemistry staining for FSP-1 expression in ascitic MCAs. FSP-1-positive MCAs were detectedin all 12 patients studied. Scale bars, 20 µm. (B) Representative images of immunohistochemical staining for FAP expression in ascitic MCAs. FAP-positive MCAs were detectedin all 12 patients studied. Scale bars, 20 µm. CAFs, cancer-associated fibroblasts; MCAs, multicellular aggregates; FSP-1, fibroblast-specific protein 1; FAP, fibroblast activation protein.
. MCAs were predominantly composed of tumor cells. (A) Representative images of immunohistochemical staining for Moc-31 (epithelial tumor marker), PAX8 (ovarian cancer marker) and Ki-67 expression in ascitic MCAs. Scale bars, 20 µm. (B) Representative images of immunohistochemical staining for mesothelial markers, including claudin 4, calretinin and ER. Scale bars, 20 µm. MCAs, multicellular aggregates; ER, estrogen receptor. Figure S3 . The number and size of the MCAs increased with an increasing proportion of CAFs. Representative images of MCA formation assays. The cell suspensions contained an increasing proportion of CAFs from 0 to 1:8, 1:5 and 1:1. Scale bars, 200 µm. MCAs, multicellular aggregates; CAFs, cancer-associated fibroblasts.
